Literature DB >> 6975317

Alloreactive cloned T cell lines. V. Differential kinetics of IL 2, CSF, and BCSF release by a cloned T amplifier cell and its variant.

J M Ely, M B Prystowsky, L Eisenberg, J Quintans, E Goldwasser, A L Glasebrook, F W Fitch.   

Abstract

A noncytolytic, Thy-1+, MIs-responsive cloned T amplifier cell, designated L2, derived from secondary C57BL/6 anti-DBA/2 mixed leukocyte culture was found to produce IL 2 (Interleukin 2), granulocyte/macrophage colony-stimulating factor (CSF), and a polyclonal B cell-stimulating factor (BCSF) after alloantigenic stimulation. IL 2 activity was present transiently, with maximal levels observed 12 to 24 hr after exposure to alloantigen. Only trace amounts were present 96 hr after initiation of culture. CSF and BCSF activities were present at high levels by 24 hr and remained elevated throughout an 8-day culture period. Further evidence that the lymphokine(s) having IL 2 activity is different from those having CSF and BCSF activities was provided by L2V, a variant of L2 that did not produce IL 2. The time course of CSF and BCSF production by L2V after stimulation with alloantigen was similar to that found with L2, although IL 2 activity was not detected at any time. Since the release of lymphokines from both L2 and L2V cells could be induced by Con A in the absence of stimulating alloantigen, it is likely that the biologically active factors were produced by the cloned T cell.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975317

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Synergistic effects of antigen and soluble T-cell factors in B-lymphocyte activation.

Authors:  M L Jelachich; M J Grusby; D Clark; D Tasch; E Margoliash; S K Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

2.  An allospecific murine T helper clone which can help both T and B cell responses in vitro and in vivo.

Authors:  I N Crispe; N R Gascoigne; T Owens
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

3.  Development of a human T-cell hybridoma secreting separate B-cell growth and differentiation factors.

Authors:  J L Butler; R J Falkoff; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

4.  Multiple hemopoietic lineages are found after stimulation of mouse bone marrow precursor cells with interleukin 3.

Authors:  M B Prystowsky; G Otten; M F Naujokas; J Vardiman; J N Ihle; E Goldwasser; F W Fitch
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

5.  A microassay for colony-stimulating factor based on thymidine incorporation.

Authors:  M B Prystowsky; M F Naujokas; J N Ihle; E Goldwasser; F W Fitch
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

6.  Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte.

Authors:  J C Reed; D E Sabath; R G Hoover; M B Prystowsky
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

7.  Interleukin 1 production by peripheral blood mononuclear cells from leprosy patients.

Authors:  S Watson; W Bullock; K Nelson; V Schauf; R Gelber; R Jacobson
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

8.  Precursor frequency analysis of lymphokine-secreting alloreactive T lymphocytes. Dissociation of subsets producing interleukin 2, macrophage-activating factor, and granulocyte-macrophage colony-stimulating factor on the basis of Lyt-2 phenotype.

Authors:  A Kelso; H R Macdonald
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

9.  The production of lymphokines by primary alloreactive T-cell clones: a co-ordinate analysis of 233 clones in seven lymphokine assays.

Authors:  C J Sanderson; M Strath; D J Warren; A O'Garra; T B Kirkwood
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

10.  Requirement for three signals in B cell responses. II. Analysis of antigen- and Ia-restricted T helper cell-B cell interaction.

Authors:  R H Zubler; O Kanagawa
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.